Dehaier Medical Systems (DHRM) 4.78 $DHRM
Dehaier Obtained Authorization From Olympus
GlobeNewswire - Wed Apr 30, 8:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company"
, an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced it has become the authorized agent of Olympus (Beijing) Sales & Service Co., Ltd. ("Olympus" to supply its electronic gastroscope and electronic bronchoscope products to participate in several medical device procurement projects funded by the Chinese government. Pursuant to the authorization letter with Olympus, Dehaier will be responsible for bidding, agreement negotiation and execution of the projects.
Dehaier Medical Attends China International Medical Equipment Fair
GlobeNewswire - Wed Apr 23, 7:30AM CDT
Dehaier Medical Systems Ltd. (NasdaqHRM) ("Dehaier" or the "Company", an emerging leader in development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that the Company attended the China International Medical Equipment Fair ("CMEF" or the "Fair", held from April 17 to 20, 2014 in Shenzhen and cooperated with Timesco in marketing campaigns related to the Fair.
Dehaier Acquired Multiple International Players' Authorization for Chinese Government Procurement
GlobeNewswire - Wed Apr 16, 7:30AM CDT
Dehaier Medical Systems Ltd. (NasdaqHRM) ("Dehaier" or the "Company", an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that it will serve as the exclusive product-appointed distribution agent for some of the world's leading medical equipment companies in bidding for multiple government procurement projects in China, the procurement projects we are bidding for are designated by these companies.
Nasdaq stocks posting largest percentage decreases
AP - Tue Apr 15, 12:55PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Dehaier Medical elects Huili (Alisa) Li as new CFO
M2 - Mon Apr 14, 9:01AM CDT
Medical device company Dehaier Medical Systems (NasdaqCMHRM) disclosed on Friday the addition of Huili (Alisa) Li as its new chief financial officer and director.
Dehaier Medical Appoints New Chief Financial Officer
GlobeNewswire - Fri Apr 11, 7:30AM CDT
Dehaier Medical Systems Ltd. (NasdaqHRM) ("Dehaier" or the "Company", an emerging leader in development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that it has appointed Huili (Alisa) Li as its new Chief Financial Officer and as a Director, in both cases to replace Mr. Jingli (Charles) Li, who resigned on April 8, 2014. Mr. Li resigned these positions solely for personal reasons and not due to any disagreement with the Company. Alisa Li will serve the remainder of Charles Li's term as Director, which term expires in 2014 and will face re-election at Dehaier's annual general meeting of shareholders in 2014.
Dehaier Medical Announces 2013 Full Year Financial Results
GlobeNewswire - Mon Mar 31, 4:00PM CDT
Dehaier Medical Systems Ltd. (NasdaqHRM) ("Dehaier" or the "Company", an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its 2013 Full Year financial results ended December 31, 2013.
Dehaier Medical Schedules 2013 Full Year Financial Results
GlobeNewswire - Mon Mar 24, 7:05AM CDT
Dehaier Medical Systems Ltd. (NasdaqHRM) ("Dehaier" or the "Company", an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products, today announced that the Company plans to release its financial results for the full year of 2013 ended December 31, 2013 on Monday, March 31, 2014, after the stock market closes.
Dehaier Announces Closing of $6.7 Million Registered Direct Offering of Common Shares and Warrants
GlobeNewswire - Wed Feb 26, 8:43AM CST
Dehaier Medical Systems Ltd. (NasdaqHRM) ("Dehaier" or the "Company", an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced the closing of a previously announced securities purchase agreement (the "Securities Purchase Agreement" with certain institutional investors for the sale of 734,700 common shares in a registered offering at the price of $9.12 per common share.
Dehaier Announces Entry Into Agreement for $6.7 Million Registered Direct Offering of Common Shares and Warrants
GlobeNewswire - Fri Feb 21, 8:30AM CST
Dehaier Medical Systems Ltd. (NasdaqHRM) ("Dehaier" or the "Company", an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it entered into a securities purchase agreement (the "Securities Purchase Agreement" with certain institutional investors for the sale of 737,700 common shares in a registered offering at the price of $9.12 per common share. After payment of expenses, the Company will receive approximately $6.1 million in net proceeds. In addition, warrants to purchase 220,410 common shares in the aggregate will be issued to the investors. If fully exercised, the Company would receive aggregate gross proceeds from the warrants of approximately $2.6 million.
Cannabis Sector Briefing: Company Launches Natural Resource Development Program for Marijuana & Hemp Products
PR Newswire - Thu Feb 20, 9:16AM CST
Healthcare Market updates and Medical Marijuana sector news & developments: PetroTech Oil and Gas Inc. (OTC: PTOG), GW Pharmaceuticals plc, (NASDAQ: GWPH), Medical Marijuana, Inc. (OTC: MJNA), Dehaier Medical Systems Ltd. (NASDAQ: DHRM) and Hemp, Inc. (OTC: HEMP)
Dehaier Extends Exclusive Distribution Authorization With Timesco
GlobeNewswire - Tue Feb 18, 8:00AM CST
Dehaier Medical Systems Ltd. (NasdaqHRM) ("Dehaier" or the "Company", an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it received the exclusive distribution right renewal from Timesco in related to CLX laryngoscope products. Pursuant to the renewal agreement, Dehaier will continue to have the exclusive right to direct sale, distribute and bid of optima range products, including CLX and Eclipse blades and handles in mainland China through 2014.
Dehaier Obtained Authorization From Olympus
GlobeNewswire - Wed Apr 30, 8:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company", an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced it has become the authorized agent of Olympus (Beijing) Sales & Service Co., Ltd. ("Olympus" to supply its electronic gastroscope and electronic bronchoscope products to participate in several medical device procurement projects funded by the Chinese government. Pursuant to the authorization letter with Olympus, Dehaier will be responsible for bidding, agreement negotiation and execution of the projects. Dehaier Medical Attends China International Medical Equipment Fair
GlobeNewswire - Wed Apr 23, 7:30AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company", an emerging leader in development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that the Company attended the China International Medical Equipment Fair ("CMEF" or the "Fair", held from April 17 to 20, 2014 in Shenzhen and cooperated with Timesco in marketing campaigns related to the Fair. Dehaier Acquired Multiple International Players' Authorization for Chinese Government Procurement
GlobeNewswire - Wed Apr 16, 7:30AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company", an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that it will serve as the exclusive product-appointed distribution agent for some of the world's leading medical equipment companies in bidding for multiple government procurement projects in China, the procurement projects we are bidding for are designated by these companies. Nasdaq stocks posting largest percentage decreases
AP - Tue Apr 15, 12:55PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Dehaier Medical elects Huili (Alisa) Li as new CFO
M2 - Mon Apr 14, 9:01AM CDT
Medical device company Dehaier Medical Systems (NasdaqCM
HRM) disclosed on Friday the addition of Huili (Alisa) Li as its new chief financial officer and director. Dehaier Medical Appoints New Chief Financial Officer
GlobeNewswire - Fri Apr 11, 7:30AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company", an emerging leader in development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that it has appointed Huili (Alisa) Li as its new Chief Financial Officer and as a Director, in both cases to replace Mr. Jingli (Charles) Li, who resigned on April 8, 2014. Mr. Li resigned these positions solely for personal reasons and not due to any disagreement with the Company. Alisa Li will serve the remainder of Charles Li's term as Director, which term expires in 2014 and will face re-election at Dehaier's annual general meeting of shareholders in 2014. Dehaier Medical Announces 2013 Full Year Financial Results
GlobeNewswire - Mon Mar 31, 4:00PM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company", an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its 2013 Full Year financial results ended December 31, 2013. Dehaier Medical Schedules 2013 Full Year Financial Results
GlobeNewswire - Mon Mar 24, 7:05AM CDT
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company", an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products, today announced that the Company plans to release its financial results for the full year of 2013 ended December 31, 2013 on Monday, March 31, 2014, after the stock market closes. Dehaier Announces Closing of $6.7 Million Registered Direct Offering of Common Shares and Warrants
GlobeNewswire - Wed Feb 26, 8:43AM CST
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company", an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced the closing of a previously announced securities purchase agreement (the "Securities Purchase Agreement" with certain institutional investors for the sale of 734,700 common shares in a registered offering at the price of $9.12 per common share. Dehaier Announces Entry Into Agreement for $6.7 Million Registered Direct Offering of Common Shares and Warrants
GlobeNewswire - Fri Feb 21, 8:30AM CST
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company", an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it entered into a securities purchase agreement (the "Securities Purchase Agreement" with certain institutional investors for the sale of 737,700 common shares in a registered offering at the price of $9.12 per common share. After payment of expenses, the Company will receive approximately $6.1 million in net proceeds. In addition, warrants to purchase 220,410 common shares in the aggregate will be issued to the investors. If fully exercised, the Company would receive aggregate gross proceeds from the warrants of approximately $2.6 million. Cannabis Sector Briefing: Company Launches Natural Resource Development Program for Marijuana & Hemp Products
PR Newswire - Thu Feb 20, 9:16AM CST
Healthcare Market updates and Medical Marijuana sector news & developments: PetroTech Oil and Gas Inc. (OTC: PTOG), GW Pharmaceuticals plc, (NASDAQ: GWPH), Medical Marijuana, Inc. (OTC: MJNA), Dehaier Medical Systems Ltd. (NASDAQ: DHRM) and Hemp, Inc. (OTC: HEMP)
Dehaier Extends Exclusive Distribution Authorization With Timesco
GlobeNewswire - Tue Feb 18, 8:00AM CST
Dehaier Medical Systems Ltd. (Nasdaq
HRM) ("Dehaier" or the "Company", an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it received the exclusive distribution right renewal from Timesco in related to CLX laryngoscope products. Pursuant to the renewal agreement, Dehaier will continue to have the exclusive right to direct sale, distribute and bid of optima range products, including CLX and Eclipse blades and handles in mainland China through 2014. 
